Syncope is the abrupt and transient loss of consciousness due to a temporary reduction in cerebral blood flow. It is associated with an absence of postural tone and followed by a rapid and usually complete recovery. Syncope may be both benign or the only warning before an episode causing sudden death (1). Recurrent episodes of syncope may result from a variety of disorders, all of which cause a temporary reduction in cerebral blood flow sufficient to disturb the normal functions of the brain. Neurocardiogenic (vasovagal) syncope is the most common of a group of reflex (neurally mediated) syncopes, characterized by a sudden failure of the autonomic nervous system (ANS) to maintain blood pressure, and occasionally heart rate, at a level sufficient to maintain cerebral perfusion and consciousness (2–4). Syncope accounts for 3.5% of all emergency room visits and 1–6% of all hospital admissions annually in the USA (5).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Grubb BP: Neurocardiogenic syncope. In: Syncope: mechanisms and management. Grubb B, Olshansky B (Eds.) Malden, Mass, Blackwell/Futura Publishing 47–71 (2005).
Grubb BP, Karas B: Clinical disorders of the autonomic nervous system associated with orthostatic intolerance: an overview of classification, clinical evaluation, and management. Pacing Clin. Electrophysiol. 22(5), 798–810 (1999).
Wieling W, van Lieshout J: Maintenance of postural normotension in humans. In: Clinical Autonomic Disorders: Evaluation and Management, 2nd Edition. Low PA (Ed.), Philadelphia, Lippincott-Raven, PA, USA 73–82 (1997).
Shepherd RFJ, Shepherd JT: Control of the blood pressure and the circulation in man. In: Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System, 4th Edition. Mathias CJ, Bannister R (Eds.), Oxford University Press, Oxford, England, 72–75 (1999).
Goldschlager N, Epstein AE, Grubb BP et al.: Etiologic considerations in the patient with syncope and an apparently normal heart. Arch. Intern. Med. 163, 151–162 (2003).
Bannister R, Mathias CJ: Introduction and classification of autonomic disorders. In: Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System. Mathias C, Bannister R (Eds.) Oxford Press, Oxford, UK, xvii–xxii (1999).
Calabrese R, Gordon T, Hawkins R, Qian N: Essentials of Neural Science and Behaviour. Appleton & Lange, Norwalk, CT (1995).
Bennaroch E: The Central Autonomic Network: Functional Organization and Clinical Correlations. Futura Press, Armonk, NY, USA (1997).
Appenzeller O, Oribe E: The Autonomic Nervous System: An Introduction to Basic and Clinical Concepts. Elsevier Science, Amsterdam, The Netherlands (1997).
Joyner M, Sheppard T: Autonomic regulation of the circulation. In: Clinical Autonomic Disorders, 2nd Edition. Low P (Ed.), Lippincott-Raven, Philadelphia, PA 61–71 (1997).
Thompson WO, Thompson PK, Dailey ME: The effect of upright posture on the composition and volume of the blood in man. J. Clin. Invest. 5, 573–609 (1988).
Consensus Committee of the American Autonomic Society and the American Academy of Neurology on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Neurology 46, 1470–1471 (1996).
Chen LY, Shen WK, Mahoney DW, et al.: Prevalence of self-reported syncope: an epidemiologic study from Olmsted County, MN [abstract]. J. Am. Coll. Cardiol. 39, 114A–115A (2002).
Sheldon R, Rose S, Flanagan P, et al.: Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation 93, 973–981 (1996).
Grimm W, Degenhardt M, Hoffman J, et al.: Syncope recurrence can better be predicted by history than by head-up tilt testing in untreated patients with suspected neurally mediated syncope. Eur. Heart. J. 18, 1465–1469 (1997).
Natale A, Geiger MJ, Maglio C, et al.: Recurrence of neurocardiogenic syncope without pharmacologic interventions. Am. J. Cardiol. RF77, 1001–1003 (1996).
Benditt DG, Sutton R, Gammage MD, et al.: Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. The International Rate-Drop Investigators Group. Pacing. Clin. Electrophysiol. 20, 832–839 (1997).
Petersen ME, Chamberlain-Webber R, Fitzpatrick AP, et al.: Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br. Heart. J. 71, 274–281 (1994).
Sheldon R, Koshman ML, Wilson W, et al.: Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope. Am. J. Cardiol. 81, 158–162 (1998).
Connolly SJ, Sheldon R, Roberts RS, Gent M. The North American vasovagal pacemaker study (VPS): a randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J. Am. Coll. Cardiol. 33, 16–20 (1999).
Linzer M, Pontinen M, Gold DT, et al.: Impairment of physical and psychosocial function in recurrent syncope. J. Clin. Epidemiol. 44, 1037–1043 (1991).
Rose MS, Koshman ML, Spreng S, et al.: The relation between health-related quality of life and frequency of spells in patients with syncope. J. Clin. Epidemiol. 53, 1209–1216 (2000).
Mosqueda-Garcia R, Furlan R, Tank J, Fernandez-Violante R: The elusive pathophysiology of neurally mediated syncope. Circulation 102, 2898–2906 (2000).
Kosinski D, Grubb BP, Temesy-Armos P: Pathophysiological aspects of neurocardiogenic syncope: current concepts and new perspectives. Pacing Clin. Electrophysiol. 18, 716–724 (1995).
Grubb BP, Karas BJ: The potential role of serotonin in the pathogenesis of neurocardiogenic syncope and related autonomic disturbances. J. Intervent. Cardiac Electrophysiol. 2, 325–332 (1998).
Lurie KG, Benditt D: Syncope and the autonomic nervous system. J. Cardiovasc. Electrophysiol. 7, 760–776 (1996).
Linzer M, Yang EH, Estes NA III et al.: Diagnosing syncope. 1. Value of history, physical examination, and electrocardiography: Clinical Efficacy Assessment Project of the American College of Physicians. Ann. Intern. Med. 126, 989–996 (1997).
Brignole M, Menozzi C, Bartoletti A et al.: For the Evaluation of Guidelines in Syncope Study 2 (EGSYS-2) group: a new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur. Heart J. 27(1), 76–82 (2006).
Brignole M, Alboni P, Benditt D et al.: Task force on syncope, European Society of Cardiology. Guidelines on management (diagnosis and treatment) of syncope–Update 2004. Executive summary. Europace 6, 467–537 (2004).
Grubb BP, Kosinski D: Tilt table testing: concepts and limitations. Pacing Clin. Electrophysiol. 20, 781–787 (1997).
Grubb BP: Tilt table testing. In: Syncope: mechanisms and management. Grubb B, Olshansky B (Eds.) Blackwell/Futura Publishing, Malden, MA (2005).
Garcia-Civera R, Ruiz-Granell R, Morell-Cabedo S et al.: Significance of tilt table testing in patients with suspected arrhythmic syncope and negative alectrophysiologic study. J. Cardiovasc. Electrophysiol. 16(9), 938–942 (2005).
Sagristà-Sauleda J, Romero B, Permanyer-Miralda G, Moya A, Soler-Soler J: Reproducibility of sequential head-up tilt testing in patients with recent syncope, normal ECG and no structural heart disease. Eur. Heart J. 23, 1706–1713 (2002).
Kenny RA, O’Shea D, Parry SW: The Newcastle protocols for head-up tilt table testing in the diagnosis of vasovagal syncope, carotid sinus hypersensitivity, and related disorders. Heart 83, 564–569 (2000).
Sutton R, Brignole M, Menozzi C et al. for the Vasovagal Syncope International Study (VASIS) Investigators: Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy: a multicenter randomized study. Circulation 102(3), 294–299 (2000).
Hermosillo AG, Jordan JL, Vallejo M, Kostine A, Marquez MF, Cardenas M: Cerebrovascular blood flow during the near syncopal phase of head-up tilt test: a comparative study in different types of neurally mediated syncope. Europace 8(3), 199–203 (2006).
Sutton R, Benditt D: The basic autonomic assessment. In: The Evaluation and Management of Syncope. Benditt D, Blanc JJ, Brignole M, Sutton R (Eds.). Blackwell-Futura, Malden, MA 71–79 (2003).
Krahn A, Klein GJ, Yee R, Skanes AC: Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 104, 46–51 (2001).
Menozzi C, Brignole M, Garcia-Civera R et al.: International Study on Syncope of Uncertain Etiology (ISSUE): mechanism of syncope in patients with heart disease and negative electrophysiologictest. Investig. Circulation 105(23), 2741–2745 (2002).
Benditt D, Ferguson D, Grubb BP, Kapoor WN, Kugler J, Lerman BB: Tilt table testing for accessing syncope and its treatment: an American College of Cardiology Consensus document. J. Am. Coll. Cardiol. 28, 263–267 (1996).
Brignole M, Alboni P, Benditt L et al.: Guidelines on the management, diagnosis and treatment of syncope. Euro. Heart J. 22, 1256–1306 (2001).
Grubb BP, Samoil D, Kosinski D et al.: Cerebral syncope: loss of consciousness associated with cerebral vasoconstriction in the absence of systemic hypotension. Pacing Clin. Electrophysiol. 21, 652–658 (1988).
Grubb BP, Gerard G, Wolfe DA, Samoil D, Davenport CW, Homan RW: Syncope and seizure of psychogenic origin: identification with head upright tilt table testing. Clin. Cardiol. 15, 839–842 (1992).
Krahn AD, Klein GJ, Norris C, Yee R. The etiology of Syncope in patients with negative tilt table and electrophysiological testing. Circulation 92, 1819–1824 (1995).
Garcia-Civera R, Ruiz-Granell R, Morell-Cabedo S, et al. Selective use of diagnostic tests in patients with syncope of unknown cause. JACC 41, 787–790 (2003).
Krahn AD, Klein GJ, Yee R, Takle-Newhouse T, Norris C. Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators. Circulation 99, 406–410 (1999).
Nierop PR, van Mechelen R, van Elsacker A, Luijten RH, Elhendy A. Heart rhythm during syncope and presyncope: results of implantable loop recorders. Pacing Clin. Electrophysiol. 23, 1532–1538 (2000).
Krahn AD, Klein GJ, Yee R, Norris C. Final results from a pilot study with an implantable loop recorder to determine the etiology of syncope in patients with negative non-invasive and invasive testing. Am. J Cardiol. 82, 117–119 (1998).
Ermis C, Zhu AX, Pham S, et al. Comparison of automatic and patient-activated arrhythmia recordings by implantable loop recorders in the evaluation of syncope. Am J Cardiol 92, 815–819 (2003).
Krahn AD, Klein GJ, Yee R, Skanes AC. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation 104, 46–51 (2001).
Moya A, Brignole M, Menozzi C, et al. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation 104, 1261–1267 (2001).
Brignole M, Menozzi C, Moya A et al. Mechanism of syncope in patients with bundle branch block and negative electrophysiological test. Circulation 104, 2045–2050 (2001).
Menozzi C, Brignole M, Garcia-Civera R, et al. Mechanism of syncope in patients with heart disease and negative electrophysiological test. Circualtion 105, 2741–2745 (2002).
Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infacrtion and reduced ejection fraction. N Engl J Med 346, 877–883 (2002).
Krahn AD, Klein GJ, Yee R, Hoch JS, Skanes AC. Cost implications of testing strategy in patients with syncope: randomized assessment of syncope trial. J Am Coll Cardiol 42, 495–501 (2003).
Michele Brignole, Richard Sutton, Carlo Menozzi, Roberto Garcia-Civera, Angel Moya, Wouter Wieling, Dietrich Andresen, David G. Benditt, Panos Vardas, and for the International Study on Syncope of Uncertain Etiology 2 (ISSUE 2) Group. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J 27(9): 1085–1092 (2006). Ebub 2006 Mar 28.
Farwell D, Freemantle N, Sulke N. Use of implantable loop recorders in the diagnosis and management of syncope. Eur Heart J 25, 1257–1263 (2004).
Kapoor W. Is there an effective treatment for neurally-mediated syncope? JAMA 289, 2272–2275 (2003).
Brignole M, Croci F, Menozzi C et al.: Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. J. Am. Coll. Cardiol. 40, 2054–2060 (2002).
Krediet P, van Dijk N, Linzer M, Lieshout J, Wieling W: Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation 106, 1684–1689 (2002).
McGrady AV, Bush EG, Grubb BP: Outcome of biofeedback-assisted relaxation for neurocardiogenic syncope and headache: a clinical replication series. Appl. Psychophysiol. Biofeedback 22 (1), 63–72 (1997).
McGrady AV, Kern-Buell C, Bush E, Devonshire R, Claggett AL, Grubb BP: Biofeedback-assisted relaxation therapy in neurocardiogenic syncope: a pilot study. Appl. Psychophysiol. Biofeedback 28(3), 183–192 (2003).
Younoszai AK, Franklin WH, Chan DP, Cassidy SC, Allen HD: Oral fluid therapy: a promising treatment for vasodepressor syncope. Arch. Pediatr. Adolesc. Med. 152, 165–168 (1998).
El-Sayed H, Hainsworth R: Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart 75, 134–140 (1996).
Ector H, Reybrouck T, Heidbuchel H, Gewillig M, Van de Werf F: Tilt training: a new treatment for recurrent neurocardiogenic syncope or severe orthostatic intolerance. Pacing Clin. Electrophysiol. 21, 193–196 (1998).
Foglia Manzillo G, Giada F, Gaggioli G et al.: Efficacy of tilt training in the treatment of neurally mediated syncope: a randomized study. Europace 6, 199–204 (2004).
Brignole M: Randomized clinical trials of neurally mediated syncope. J. Cardiovasc. Electrophysiol. 14, S64–S69 (2003).
Brignole M, Menozzi C, Gianfranchi L, Lolli G, Bottoni N, Oddone D: A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am. J. Cardiol. 70, 339–342 (1992).
Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S: Effect of S blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am. J. Cardiol. 78, 536–539 (1996).
Di Girolamo E, Di Iorio C, Sabatini P et al.: Evaluation of the effects of diverse therapeutic treatments versus no treatment of patients with neurocardiogenic syncope. Cardiologia 43, 833–837 (1998).
Madrid AH, Ortega J, Rebollo JG et al.: Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study. J. Am. Coll. Cardiol. 37, 554–559 (2001).
Ventura R, Maas R, Zeidler D et al.: A randomized and controlled pilot trial of V-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test. Pacing Clin. Electrophysiol. 25, 816–821 (2002).
Flevari P, Livanis EG, Theodorakis GN, Zarvalis E, Mesiskli T, Kremastinos DT: Vasovagal syncope: a prospective, randomized, cross-over evaluation of the effects of propranolol, nadolol and placebo on syncope recurrence and patients’ well-being. J. Am. Coll. Cardiol. 40, 499–504 (2002).
Sheldon R, Connolly S, Rose S et al. and the POST Investigators: Prevention Of Syncope Trial (POST): a randomized pacebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 113(9), 1164–1170 (2006).
Hickler RB, Thompson GR, Fox LM, Hamlin JT: Successful treatment of orthostatic hypotension with 9-X-fluohydrocortisone. N. Engl. J. Med. 261, 788–791 (1959).
Scott WA, Pongiglione G, Bromberg BI et al.: Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am. J. Cardiol. 76, 400–402 (1995).
Grubb BP, Kosinski D: Orthostatic hypotension: causes, classification and treatment. Pacing Clin. Electrophysiol. 26, 892–901 (2003).
Parry SW, Kenny RA: The management of vasovagal syncope. QJM 92, 697–705 (1999).
Low PA, Gilden JL, Freeman R et al.: Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension: a randomized, double-blind multicenter study. JAMA 278, 388 (1997).
Ward CR, Gray JC, Gilroy JJ, Kenny RA: Midodrine: a role in the management of neurocardiogenic syncope. Heart 79, 45–49 (1998).
Singer W, Opfen-Gehrking, McPhee BR, Hiltz MJ, Bharucha AE, Low P: Acetylcholinesterase inhibition: a novel approach in the treatment of orthostatic hypotension. J. Neurol. Neurosurg. Psychiatry 74, 1294–1298 (2003).
Kuhn DM, Wolfe WA, Lovenberg W: Review of the central serotonergic neuronal system in blood pressure regulation. Hypertension 2, 243–255 (1980).
Grubb BP, Wolfe DA, Samoil D, Temesy-Armos P, Hahn H, Elliott L: Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt-induced syncope. Pacing Clin. Electrophysiol. 16, 458–464 (1993).
Benditt D, Peterson ME, Lurie K, et al. Cardiac pacing for prevention of recurrent vasovagal syncope. Ann Intern Med 122, 204–209 (1995).
Di Girolamo E, Di Iorio C, Sabatini P, Leonzio L, Barbone C, Barsotti A: Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J. Am. Coll. Cardiol. 33, 1227–1230 (1999).
Hoeldkte RD, Streeten DH: Treatment of orthostatic hypotension with erythropoietin. N. Engl. J. Med. 329, 611–615 (1993).
Biaggioni S, Robertson D, Krantz S, Jones M, Hale V: The anemia of primary autonomic failure and its reversal with recombinant erythropoietin. Ann. Intern. Med. 121, 181–186 (1994).
Grubb BP, Lachant N, Kosinski D: Erythropoietin as a therapy for severe refractory orthostatic hypotension. Clin. Auton. Res. 4, 212 (1994) (Abstract).
Fitzpatrick AP, Travill CM, YardasPE, et al. Recurrent symptoms after ventricular pacing in unexplained syncope. Pacing Clin Electrophysiol. 1990;13:619–624.
Kenny RA, Ingram A, Baylor J, Sutton R. Head up tilt: a useful test for explaining unexplained syncope. Lancet 1, 1352–1355 (1989).
Fitzpatrick A, Sutton R. Tilting toward a diagnosis in recurrent unexplained syncope. Lancet 1, 658–660 (1989).
Fitzpatrick A, Theodorakis G, Ahmed R. Dual Chamber pacing aborts vasovagal syncope induced by head up 60 degree tilt. Pacing Clin Electrophysiol 14, 13–19 (1991).
McGuinn P, Moore S, Edel T, et al. Temporary dual chamber pacing during tilt table testing for vasovagal syncope: predictor of therapeutic success (Abstract). Pacing Clin Electrophysiol 14, 734 (1991).
Samoil D, Grubb BP, Brewster P, et al. Comparison of single and dual chamber pacing techniques in the prevention of upright tilt-induced vasovagal syncope. Eur J Card Pacing Electrophysiol 3, 36–41 (1993).
Sra J, Jazayeri M, Avitall B et al. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med 328, 1085–1090 (1993).
Ammirati F, Colivicchi F, Toscano S et al. DDD pacing with rate-drop function versus DDI with rate hysteresis pacing for cardioinhibitory vasovagal sncope. PACE 21, 2178–2181 (1998).
Ammirati F, Colivicchi F, Santini M. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized controlled trial. Circulation 104, 52–57 (2001).
Connolly S, Sheldon R, Thorpe K, et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope. Second vasovagal pacemaker study (VPSII): a randomized trial. JAMA 289, 2224–2229 (2003).
Giada F, Raviele A, Menozzi C, et al. The vasovagal syncope and pacing trial (SYNPACE): a randomized placebo controlled study of permanent cardiac pacing for treatment of recurrent vasovagal syncope. PACE 26, 1016 (2003).
Raj SR, Koshman ML, Sheldon RS: Five-year follow-up of patients with dual chamber pacemakers for vasovagal syncope [abstract]. Can J Cardiol 18, xxx (2002).
Gabriel Gregoratos, Melvin D. Cheitlin, Alicia Conill, Andrew E. Epstein, Christopher Fellows, T. Bruce Ferguson, Jr, Roger A. Freedman, Mark A. Hlatky, Gerald V. Naccarelli, Sanjeev Saksena, Robert C. Schlant, and Michael J. Silka. ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). Circulation 98, 1325–1335 (1998).
McLeod K, Wilson N, Hewitt J et al. Cardiac pacing for severe childhood neurally mediated syncope with reflex anoxic seizures. Heart 82, 721–725 (1999).
Sutton R. Has cardiac pacing a role in vasovagal syncope? J Interv Card Electrophysiol 9, 145–149 (2003).
Sra JS. Can we assess the efficacy of therapy in neurocardiogenic syncope? J Am Coll Cardiol 37, 560–561 (2001).
Moss AJ, Glaser W, Topal E. Atrial tachypacing in the treatment of a patient with primary orthostatic hypotension. N Engl J Med 302, 1456–1457 (1980).
Weismann P, Chin M, Moss AJ. Cardiac tachypacing for severe refractory idiopathic orthostatic hypotension. Ann Intern Med 116, 650–651 (1992).
Abe H, Numata T, Hanada H, Kohshi K, Nakashima Y. Successful treatment of severe orthostatic hypotension with cardiac tachypacing in dual chamber pacemakers. Pacing Clin Electrophysiol 23, 137–139 (2000).
Sahul ZH, Trusty JM, Erickson M, Low PA, Shen WK. Pacing does not improve hypotension in patients with severe orthostatic hypotension–a prospective randomized cross-over pilot study. Clin Auton Res 14(4), 255–258 (2004).
Fortrat JO, Lemarie C, Bellard E, Victor J. Do we need a reflex tachycardia to stand up? PACE 28, 962–967 (2005).
Shannon J, Flatten NL, Jordan T et al.: Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 342, 541–549 (2000).
Schroeder C, Vernino S, Birkenfeld AL et al.: Plasma exchange for primary autoimmune autonomic failure. N Engl J Med 353(15), 1585–1590 (2005).
Kurbaan A, Erickson M, Peterson M et al. Respiratory changes in vasovagal syncope. J Cardiovasc Electrophysiol 11, 607–611 (2000).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Eltahawy, E.A., Grubb, B.P. (2008). Pacemakers and Syncope. In: Kusumoto, F.M., Goldschlager, N.F. (eds) Cardiac Pacing for the Clinician. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-72763-9_13
Download citation
DOI: https://doi.org/10.1007/978-0-387-72763-9_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-72762-2
Online ISBN: 978-0-387-72763-9
eBook Packages: MedicineMedicine (R0)